Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Ms. Amy A. McBride-WendellInsider | -1,65k | 45,70k | Derivative Exercise and Sale | 14,85 - 42,60 | 93,83k | - |
| 2026-05-07 | Mr. John H. JohnsonIndependent Director | -11,05k | 400,18k | Derivative Exercise and Sale | 7,04 - 43,26 | - | - |
| 2026-05-07 | Ms. Kathy WeilerIndependent Director | -16,34k | 607,03k | Derivative Exercise and Sale | 6,95 - 44,09 | - | - |
| 2026-05-07 | Mr. Jens Schroeder KempCMO | -4,00k | 173,76k | Verkauf | 43,44 | 72,45k | -5,23% |
| 2026-05-07 | Ms. Lindsey HartleyCFO | -1,05k | 37,24k | Derivative Exercise and Sale | 8,20 - 43,67 | 65,15k | - |
| 2026-05-07 | Ms. Lindsey HartleyCFO | 4,41k | 36,35k | Derivative Exercise and Retained Stock | 8,20 - 8,27 | 65,15k | 7,26% |
| 2026-05-07 | Ms. Doris QuackenbushVP of Sales | -3,88k | 168,72k | Verkauf | 43,51 | 92,42k | -4,03% |
| 2026-03-16 | Mr. Erick DeVinneyChief Innovation Officer | -8,09k | 265,71k | Derivative Exercise and Sale | 32,84 | 237,78k | - |
| 2026-03-16 | Mr. Erick DeVinneyChief Innovation Officer | 9,85k | 0,00 | Derivative Exercise and Retained Stock | - | 237,78k | 4,32% |
| 2026-03-16 | Ms. Lindsey HartleyCFO | -3,54k | 116,32k | Derivative Exercise and Sale | 32,84 | 60,73k | - |
| 2026-03-16 | Ms. Lindsey HartleyCFO | 5,46k | 0,00 | Derivative Exercise and Retained Stock | - | 60,73k | 9,87% |
| 2026-02-26 | Mr. Jens Schroeder KempCMO | -18,37k | 582,19k | Sale to Issuer | 30,65 - 31,90 | 76,45k | -19,37% |
| 2026-03-01 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | 6,82k | 0,00 | Derivative Exercise and Retained Stock | - | 50,14k | 15,75% |
| 2026-03-01 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -4,43k | 135,69k | Derivative Exercise and Sale | 30,65 | 50,14k | - |
| 2026-02-26 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -8,75k | 279,22k | Sale to Issuer | 31,90 | 50,14k | -14,86% |
| 2026-02-26 | Mr. Erick DeVinneyChief Innovation Officer | -21,98k | 687,00k | Sale to Issuer | 30,65 - 31,90 | 215,43k | -9,26% |
| 2026-02-26 | Ms. Lindsey HartleyCFO | -6,63k | 211,50k | Sale to Issuer | 31,90 | 55,28k | -10,71% |
| 2026-02-22 | Ms. Lindsey HartleyCFO | -6,70k | 237,19k | Sale to Issuer | 35,38 | 44,45k | -13,10% |
| 2025-12-15 | Ms. Lindsey HartleyCFO | -14,81k | 319,80k | Derivative Exercise and Sale | 8,27 - 29,86 | 31,38k | - |
| 2025-12-16 | Ms. Kathy WeilerIndependent Director | -40,07k | 903,89k | Derivative Exercise and Sale | 6,95 - 29,55 | - | - |
| 2025-12-16 | Ms. Kathy WeilerIndependent Director | -6,58k | 194,44k | Verkauf | 29,55 | 0,00 | -100,00% |
| 2025-12-16 | Ms. Amy A. McBride-WendellInsider | -43,68k | 978,50k | Derivative Exercise and Sale | 6,30 - 29,31 | 93,83k | - |
| 2025-12-11 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -13,22k | 396,66k | Verkauf | 30,00 | 18,29k | -41,97% |
| 2025-12-10 | Mr. Michael D. DalePresident, CEO & Director | -25,00k | 750,00k | Verkauf | 30,00 | 63,54k | -28,24% |
| 2025-12-09 | Dr. Joseph TyndallIndependent Director | -25,11k | 558,55k | Derivative Exercise and Sale | 7,04 - 30,98 | 0,00 | - |
| 2025-12-09 | Mr. Michael D. DalePresident, CEO & Director | -61,46k | 1,92M | Verkauf | 31,21 | 88,54k | -40,98% |
| 2025-12-09 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -9,28k | 289,55k | Verkauf | 31,21 | 31,51k | -22,75% |
| 2025-12-09 | Mr. Jens Schroeder KempCMO | -8,16k | 254,53k | Verkauf | 31,21 | 46,03k | -15,05% |
| 2025-12-09 | Mr. Erick DeVinneyChief Innovation Officer | -19,52k | 609,09k | Verkauf | 31,21 | 191,13k | -9,27% |
| 2025-12-08 | Ms. Lindsey HartleyCFO | 10,61k | 161,53k | Derivative Exercise and Retained Stock | 15,22 | 31,38k | 51,11% |
| 2025-12-08 | Ms. Lindsey HartleyCFO | -14,39k | 270,13k | Derivative Exercise and Sale | 8,20 - 31,56 | 31,38k | - |
| 2025-12-08 | Mr. John H. JohnsonIndependent Director | -20,44k | 498,72k | Derivative Exercise and Sale | 6,30 - 31,22 | 0,00 | - |
| 2025-12-08 | Mr. John H. JohnsonIndependent Director | -24,94k | 762,92k | Verkauf | 29,98 - 31,26 | 0,00 | -100,00% |
| 2025-12-09 | Mr. Paul G. ThomasIndependent Chairman of the Board | -21,40k | 633,71k | Verkauf | 29,61 | 0,00 | -100,00% |
| 2025-11-10 | Mr. William P. BurkeIndependent Director | -22,82k | 362,15k | Derivative Exercise and Sale | 8,14 - 24,02 | 100,00 | - |
| 2025-11-05 | Mr. William P. BurkeIndependent Director | -16,78k | 266,69k | Derivative Exercise and Sale | 8,14 - 24,05 | 100,00 | - |
| 2025-10-29 | Mr. William P. BurkeIndependent Director | -58,48k | 828,34k | Derivative Exercise and Sale | 6,30 - 23,00 | 100,00 | - |
| 2025-10-22 | Mr. William P. BurkeIndependent Director | -1,46k | 26,25k | Automatic Disposition | 18,02 | 100,00 | -93,58% |
| 2025-10-06 | Mr. William P. BurkeIndependent Director | -736,00 | 13,25k | Automatic Disposition | 18,00 | 1,56k | -32,10% |
| 2025-10-02 | Mr. William P. BurkeIndependent Director | -32,19k | 584,07k | Automatic Disposition | 18,01 - 18,21 | 2,29k | -93,35% |
| 2025-09-16 | Mr. Erick DeVinneyChief Innovation Officer | -1,14k | 18,52k | Verkauf | 16,29 | 170,65k | -0,66% |
| 2025-06-09 | Ms. Kathy WeilerIndependent Director | -4,07k | 43,21k | Verkauf | 10,61 | 6,58k | -38,23% |
| 2025-06-09 | Mr. Alan M. LevineIndependent Director | -4,07k | 43,21k | Verkauf | 10,61 | 36,74k | -9,98% |
| 2025-06-09 | Ms. Amy A. McBride-WendellInsider | -4,07k | 43,21k | Verkauf | 10,61 | 93,83k | -4,16% |
| 2025-06-09 | Mr. William P. BurkeIndependent Director | -4,07k | 43,21k | Verkauf | 10,61 | 24,48k | -14,26% |
| 2025-06-09 | Mr. Guido Julius NeelsInsider | -4,07k | 43,21k | Verkauf | 10,61 | 86,74k | -4,48% |
| 2025-06-09 | Mr. John H. JohnsonIndependent Director | -4,07k | 43,21k | Verkauf | 10,61 | 24,94k | -14,04% |
| 2025-06-10 | Dr. Joseph TyndallIndependent Director | -11,59k | 48,25k | Derivative Exercise and Sale | 6,30 - 10,72 | 0,00 | - |
| 2025-06-10 | Dr. Joseph TyndallIndependent Director | -15,35k | 164,50k | Verkauf | 10,72 | 0,00 | -100,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
